Investment Analysis Based on Intrinsic Value in the Information Technology and Pharmaceutical Sectors for Advancements in Digital Healthcare.
DOI:
https://doi.org/10.61173/9wjk9v89Keywords:
1930s, Benjamin Graham, David Dodd, Intrinsic ValueAbstract
In the annals of financial literature, the 1930s bore witness to a foundational shift with the publication of “Security Analysis” by Benjamin Graham and David Dodd, scholars at Columbia Business School. As articulated therein, value investing advocates for an analytical focus on equities priced beneath their calculated intrinsic or book values. Fundamentally, discerning investors target equities that, upon rigorous analysis, appear to be undervalued by prevailing market standards. Equities, in an economic construct, signify an entity’s ownership and proffer a claim on a specified tranche of its fiscal assets and revenues. To ascertain an equity’s intrinsic worth, investors meticulously examine a company’s foundational metrics, encompassing earnings, dividends, projected cash inflows, and overall fiscal robustness. The tenets of value investing transcend industry boundaries and are universally applicable. Whether in technology, healthcare, consumer goods, or industrial sectors, the principles remain valid, provided investors possess the insight to identify and leverage market inefficiencies. This paper aims to scrutinize prominent entities within the information technology and pharmaceutical arenas, interpreting their financial dynamics through the value investing paradigm.
References
digital health innovations, there’s a notable surge in IEEE Engineering Management Review, vol. 48, no. 3, 2020, pp. the assortment and capabilities of these solutions. 97–103, ieeexplore.ieee.org/abstract/document/9153093. However, juxtaposed against these progressive strides Ayati, Nayyereh, et al. “Short and Long Term Impacts of is a conspicuous deficit in trust and confidence across COVID-19 on the Pharmaceutical Sector.” DARU Journal
stakeholders — from patients and medical professionals to of Pharmaceutical Sciences, vol. 28, no. 2, 3 July 2020, link. fiscal entities, industry magnates, and regulatory bodies. springer.com/article/10.1007/s40199-020-00358-5, https://doi. To introduce transparency into the nebulous realms of the org/10.1007/s40199-020-00358-5. digital health marketplace, there emerges an imperative Graham, Benjamin, and David L Dodd. Security Analysis:
for ‘value investing,’ a paradigm that advocates for Principles and Technique. 1934. New York, Mcgraw-Hill, 2009. objective, transparent, and criteria-centric assessments of Grossglauser, M, and H Saner. “Data-Driven Healthcare: From digital health entities. Patterns to Actions.” European Journal of Preventive Cardiology,
The quintessential ethos of value investing pivots on the vol. 21, no. 2_suppl, 29 Oct. 2014, pp. 14–17, https://doi. commitment to infuse capital predicated on an enterprise’s org/10.1177/2047487314552755. Accessed 5 Sept. 2019. inherent worth, eschewing the mercurial whims of market Mathews, Simon C., et al. “Digital Health: A Path to Validation.”
sentiment or the capriciousness of transient trends. At Npj Digital Medicine, vol. 2, no. 1, 13 May 2019, www.nature. the nexus of IT and the pharmaceutical landscape, this com/articles/s41746-019-0111-3, https://doi.org/10.1038/ investment doctrine champions a perspicacious, long- s41746-019-0111-3. range orientation, fostering a robust fiscal foundation Safavi, Kyan C., et al. “Health Systems as Venture Capital that galvanizes research, development, and innovation Investors in Digital Health: 2011–2019.” Npj Digital Medicine,
of tangible consequence. By anchoring their strategies vol. 3, no. 1, 4 Aug. 2020, pp. 1–5, www.nature.com/articles/ to intrinsic value, investors, alongside corporate entities, s41746-020-00311-5, https://doi.org/10.1038/s41746-020- can strategize resource allocation with prudence, 00311-5. circumnavigate the pitfalls of market inflation, and discern undervalued prospects within the tumultuous terrains
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
